Baker Bros. Advisors’s BioTime Inc Warrants (Expiring October 1, 2018) BTX.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-20,084
Closed -$1K 124
2018
Q2
$1K Hold
20,084
﹤0.01% 119
2018
Q1
$2K Hold
20,084
﹤0.01% 114
2017
Q4
$2K Hold
20,084
﹤0.01% 123
2017
Q3
$4K Hold
20,084
﹤0.01% 121
2017
Q2
$7K Hold
20,084
﹤0.01% 120
2017
Q1
$12K Hold
20,084
﹤0.01% 119
2016
Q4
$14K Hold
20,084
﹤0.01% 133
2016
Q3
$17K Hold
20,084
﹤0.01% 134
2016
Q2
$9K Hold
20,084
﹤0.01% 135
2016
Q1
$12K Hold
20,084
﹤0.01% 134
2015
Q4
$24K Hold
20,084
﹤0.01% 133
2015
Q3
$17K Hold
20,084
﹤0.01% 133
2015
Q2
$23K Hold
20,084
﹤0.01% 126
2015
Q1
$40K Sell
20,084
-441
-2% -$591 ﹤0.01% 129
2014
Q4
$22K Buy
+20,525
New +$22.2K ﹤0.01% 121

Baker Bros. Advisors's BTX.WS Position: Q3 2018 in Review

Baker Bros. Advisors sold out of BioTime Inc Warrants (Expiring October 1, 2018) (BTX.WS) in Q3 2018, closing a stake of 20,084 shares — an estimated $1K sold.

Baker Bros. Advisors first reported a position in BTX.WS in Q4 2014 and held it in 15 quarters. The position peaked at $40K in Q1 2015. 7 funds tracked by Wall St. Rank hold BTX.WS as of Q3 2018.

  • Baker Bros. Advisors reported no remaining BioTime Inc Warrants (Expiring October 1, 2018) position as of Q3 2018 after selling out during the quarter.
  • Baker Bros. Advisors sold 20,084 BioTime Inc Warrants (Expiring October 1, 2018) shares in Q3 2018, an estimated $1K.
  • Baker Bros. Advisors first reported a position in BioTime Inc Warrants (Expiring October 1, 2018) in Q4 2014 and held it in 15 quarters.
  • Baker Bros. Advisors's BioTime Inc Warrants (Expiring October 1, 2018) position peaked at $40K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held BioTime Inc Warrants (Expiring October 1, 2018) as of Q3 2018.

Based on Baker Bros. Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.